Craig A. Johnson - 08 Jul 2022 Form 4 Insider Report for LA JOLLA PHARMACEUTICAL CO

Role
Director
Signature
/s/ Michael Hearne, by power of attorney for Craig A. Johnson
Issuer symbol
N/A
Transactions as of
08 Jul 2022
Net transactions value
+$47,160
Form type
4
Filing time
12 Jul 2022, 20:36:35 UTC
Previous filing
18 Jan 2022
Next filing
24 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LJPC Common Stock Options Exercise $47,160 +12,000 $3.93 12,000 08 Jul 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LJPC Employee Stock Option (Right to Buy) Options Exercise $0 -12,000 -100% $0.000000* 0 08 Jul 2022 Common Stock 12,000 $3.93 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a cash exercise of options that vested and became exercisable on December 20, 2020.